You are here

ALS

Researchers Cure ALS in Laboratory Animals Using Gene Therapy

Researchers Cure ALS in Laboratory Animals Using Gene Therapy

BioSpace

Lou Gehrig's disease

University of California

Flag link:

PARP inhibitors show promise for treating ALS and other brain disorders

PARP inhibitors show promise for treating ALS and other brain disorders

Fierce Biotech

PARP inhibitors

Flag link:

Orion takes repurposed heart failure drug into phase 3 for ALS

Orion takes repurposed heart failure drug into phase 3 for ALS

Fierce Biotech

clinical trials

Flag link:

ALS drug maker walks back plan to profit from right-to-try law following heavy criticism

ALS drug maker walks back plan to profit from right-to-try law following heavy criticism

Stat

BrainStorm Cell Therapeutics

right-to-try laws

clinical trials

Flag link:

Step right up: A biotech may soon sell an experimental med to dying ALS patients under ‘Right to Try’

Step right up: A biotech may soon sell an experimental med to dying ALS patients under ‘Right to Try’

Endpoints

right-to-try laws

BrainStorm Cell Therapeutics

Flag link:

Flex Pharma dumps midstage trials, cuts workforce, mulls a sale to stay alive

Flex Pharma dumps midstage trials, cuts workforce, mulls a sale to stay alive

Fierce Biotech

Flag link:

QurAlis Announces New Investors to Help Fund Drive to Cure ALS

QurAlis Announces New Investors to Help Fund Drive to Cure ALS

CP Wire

Flag link:

QurAlis Announces New Investors to Help Fund Drive to Cure ALS

Flag link:

Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer

Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer

Marketwatch

drug development

Flag link:

New target could yield treatment for Alzheimer's, ALS and more

New target could yield treatment for Alzheimer's, ALS and more

Fierce Biotech

drug development

Alzheimer's disease

Flag link:

The First ALS Drug In 22 Years Is Approved -- And It Costs 4 Times What It Does In Japan

The First ALS Drug In 22 Years Is Approved -- And It Costs 4 Times What It Does In Japan

Forbes

Flag link:

FDA OKs stem cell-gene therapy trial for ALS

FDA OKs stem cell-gene therapy trial for ALS

Drug Delivery Business

Flag link:

Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D

Backed by a biotech legend, two young entrepreneurs tackle one of the Holy Grails of R&D

Endpoints

Lou Gehrig's disease

Flag link:

Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial

Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial

TheStreet.com

BrainStorm Cell Therapeutics

clinical trials

Flag link:

Biogen, Columbia to Map ALS Disease Genes With Ice Bucket Money

Biogen, Columbia to Map ALS Disease Genes With Ice Bucket Money

Bloomberg

Columbia University

Flag link:

How a drug shift set the stage for a potential winner for ALS patients

How a drug shift set the stage for a potential winner for ALS patients

Bizjournals.com

Lou Gehrig's disease

Flag link:

Teva Pharm told to return intellectual property to Proneuron Biotechnologies

Teva Pharm told to return intellectual property to Proneuron Biotechnologies

Yahoo/Reuters

Teva Pharmaceutical

Proneuron Biotechnologies

Flag link:

What's driving the massive social media campaign for Genervon's ALS drug?

What's driving the massive social media campaign for Genervon's ALS drug?

Fierce Biotech

Lou Gehrig's disease

compassionate use guidelines

Flag link:

The FDA calls on Genervon to release data from controversial ALS study

The FDA calls on Genervon to release data from controversial ALS study

Fierce Biotech

Flag link:

Exclusive: Biogen shortens name, expands ambitions in Alzheimer's, ALS

Exclusive: Biogen shortens name, expands ambitions in Alzheimer's, ALS

Yahoo/Reuters

Alzheimer's disease

Flag link:

Pages